288 related articles for article (PubMed ID: 31664033)
1. Structural insights of human mitofusin-2 into mitochondrial fusion and CMT2A onset.
Li YJ; Cao YL; Feng JX; Qi Y; Meng S; Yang JF; Zhong YT; Kang S; Chen X; Lan L; Luo L; Yu B; Chen S; Chan DC; Hu J; Gao S
Nat Commun; 2019 Oct; 10(1):4914. PubMed ID: 31664033
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A.
Franco A; Dang X; Zhang L; Molinoff PB; Dorn GW
J Pharmacol Exp Ther; 2022 Nov; 383(2):137-148. PubMed ID: 36507849
[TBL] [Abstract][Full Text] [Related]
3. MFN1 structures reveal nucleotide-triggered dimerization critical for mitochondrial fusion.
Cao YL; Meng S; Chen Y; Feng JX; Gu DD; Yu B; Li YJ; Yang JY; Liao S; Chan DC; Gao S
Nature; 2017 Feb; 542(7641):372-376. PubMed ID: 28114303
[TBL] [Abstract][Full Text] [Related]
4. Mitofusin 1 overexpression rescues the abnormal mitochondrial dynamics caused by the Mitofusin 2 K357T mutation in vitro.
Stavropoulos F; Georgiou E; Schiza N; Bell S; Baloh RH; Kleopa KA; Sargiannidou I
J Peripher Nerv Syst; 2023 Sep; 28(3):329-340. PubMed ID: 37220142
[TBL] [Abstract][Full Text] [Related]
5. A mutation associated with CMT2A neuropathy causes defects in Fzo1 GTP hydrolysis, ubiquitylation, and protein turnover.
Amiott EA; Cohen MM; Saint-Georges Y; Weissman AM; Shaw JM
Mol Biol Cell; 2009 Dec; 20(23):5026-35. PubMed ID: 19812251
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial fusion and function in Charcot-Marie-Tooth type 2A patient fibroblasts with mitofusin 2 mutations.
Amiott EA; Lott P; Soto J; Kang PB; McCaffery JM; DiMauro S; Abel ED; Flanigan KM; Lawson VH; Shaw JM
Exp Neurol; 2008 May; 211(1):115-27. PubMed ID: 18316077
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for GTP hydrolysis and conformational change of MFN1 in mediating membrane fusion.
Yan L; Qi Y; Huang X; Yu C; Lan L; Guo X; Rao Z; Hu J; Lou Z
Nat Struct Mol Biol; 2018 Mar; 25(3):233-243. PubMed ID: 29483649
[TBL] [Abstract][Full Text] [Related]
8. Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2A.
Franco A; Dang X; Walton EK; Ho JN; Zablocka B; Ly C; Miller TM; Baloh RH; Shy ME; Yoo AS; Dorn GW
Elife; 2020 Oct; 9():. PubMed ID: 33074106
[TBL] [Abstract][Full Text] [Related]
9. Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations.
Detmer SA; Chan DC
J Cell Biol; 2007 Feb; 176(4):405-14. PubMed ID: 17296794
[TBL] [Abstract][Full Text] [Related]
10. A human mitofusin 2 mutation can cause mitophagic cardiomyopathy.
Franco A; Li J; Kelly DP; Hershberger RE; Marian AJ; Lewis RM; Song M; Dang X; Schmidt AD; Mathyer ME; Edwards JR; Strong CG; Dorn GW
Elife; 2023 Nov; 12():. PubMed ID: 37910431
[TBL] [Abstract][Full Text] [Related]
11. Defective nucleotide-dependent assembly and membrane fusion in Mfn2 CMT2A variants improved by Bax.
Samanas NB; Engelhart EA; Hoppins S
Life Sci Alliance; 2020 May; 3(5):. PubMed ID: 32245838
[TBL] [Abstract][Full Text] [Related]
12. A dominant negative mitofusin causes mitochondrial perinuclear clusters because of aberrant tethering.
Sloat SR; Hoppins S
Life Sci Alliance; 2023 Jan; 6(1):. PubMed ID: 36229071
[TBL] [Abstract][Full Text] [Related]
13. Torin1 restores proliferation rate in Charcot-Marie-Tooth disease type 2A cells harbouring MFN2 (mitofusin 2) mutation.
Zanfardino P; Amati A; Petracca EA; Santorelli FM; Petruzzella V
Acta Myol; 2022; 41(4):201-206. PubMed ID: 36793649
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A.
Kijima K; Numakura C; Izumino H; Umetsu K; Nezu A; Shiiki T; Ogawa M; Ishizaki Y; Kitamura T; Shozawa Y; Hayasaka K
Hum Genet; 2005 Jan; 116(1-2):23-7. PubMed ID: 15549395
[TBL] [Abstract][Full Text] [Related]
15. MFN2-related neuropathies: Clinical features, molecular pathogenesis and therapeutic perspectives.
Stuppia G; Rizzo F; Riboldi G; Del Bo R; Nizzardo M; Simone C; Comi GP; Bresolin N; Corti S
J Neurol Sci; 2015 Sep; 356(1-2):7-18. PubMed ID: 26143526
[TBL] [Abstract][Full Text] [Related]
16. Increased mitochondrial fusion in a autosomal recessive CMT2A family with mitochondrial GTPase mitofusin 2 mutations.
Codron P; Chevrollier A; Kane MS; Echaniz-Laguna A; Latour P; Reynier P; Bonneau D; Verny C; Procaccio V; Lenaers G; Cassereau J
J Peripher Nerv Syst; 2016 Dec; 21(4):365-369. PubMed ID: 27706887
[TBL] [Abstract][Full Text] [Related]
17. A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A.
Lv H; Wang L; Zhang W; Wang Z; Zuo Y; Liu J; Yuan Y
J Neurol Sci; 2015 Nov; 358(1-2):153-7. PubMed ID: 26382835
[TBL] [Abstract][Full Text] [Related]
18. A cohort study of MFN2 mutations and phenotypic spectrums in Charcot-Marie-Tooth disease 2A patients.
Choi BO; Nakhro K; Park HJ; Hyun YS; Lee JH; Kanwal S; Jung SC; Chung KW
Clin Genet; 2015 Jun; 87(6):594-8. PubMed ID: 24863639
[TBL] [Abstract][Full Text] [Related]
19. MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A.
Rocha AG; Franco A; Krezel AM; Rumsey JM; Alberti JM; Knight WC; Biris N; Zacharioudakis E; Janetka JW; Baloh RH; Kitsis RN; Mochly-Rosen D; Townsend RR; Gavathiotis E; Dorn GW
Science; 2018 Apr; 360(6386):336-341. PubMed ID: 29674596
[TBL] [Abstract][Full Text] [Related]
20. A catalytic domain variant of mitofusin requiring a wildtype paralog for function uncouples mitochondrial outer-membrane tethering and fusion.
Engelhart EA; Hoppins S
J Biol Chem; 2019 May; 294(20):8001-8014. PubMed ID: 30936207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
